Johnson & Johnson Ordered To Pay $572 Million For Role In Oklahoma Opioid Crisis

According to the ruling, the pharmaceutical company "engaged in false and misleading marketing of both their drugs and opioids generally."


Oklahoma Trial Of Alleged Opioid "Kingpin" Johnson & Johnson Ends

The judge's ruling is expected by the end of August.